Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay
about
Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosisMicroheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients.Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advicesSELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium diseaseThe antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasmaPeptide and protein profiles in serum and follicular fluid of women undergoing IVF.Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma.Alteration of transthyretin microheterogeneity in serum of multiple trauma patients.A combined biomarker pattern improves the discrimination of lung cancer.Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkersMaternal serum protein profile and immune response protein subunits as markers for non-invasive prenatal diagnosis of trisomy 21, 18, and 13.Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model.Prediction of individual response to anticancer therapy: historical and future perspectivesProteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.Redox proteomics of the inflammatory secretome identifies a common set of redoxins and other glutathionylated proteins released in inflammation, influenza virus infection and oxidative stress.Mass spectral analysis of urine proteomic profiles of dairy cows suffering from clinical ketosis.Does transthyretin function as one of contributors for preeclampsia?Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants.Population proteomics: the concept, attributes, and potential for cancer biomarker research.Mass spectrometry-based proteomics and its potential use in haematological research.Biomarkers for early detection of ovarian cancer.Transthyretin as a novel candidate biomarker for preeclampsia.
P2860
Q21144689-800B3B20-84E5-4F21-94B1-6441B3E4A033Q24811949-327BA6A9-F285-405F-9706-914B48244867Q28287384-BAAA77C6-C259-43DB-AE95-BE9F7D8DE896Q28389150-E64F30D2-A041-4226-9C02-94553B7FA118Q33233126-5A2066F4-B794-4B21-90C0-4DA8F7191AC3Q33253164-7DFF2BDF-D2AC-4E80-AE03-DC8735FC2DB1Q33358097-09D8438C-B03C-42C8-B303-FCC2961AD6A3Q33491559-30E3F129-578E-4F71-A725-57FC4F34A7BFQ33724593-5E78ABA6-5BF8-437C-AE6B-B20DD104D521Q34412873-532498A2-ECBB-41AD-92BB-8EB0D7C0961EQ34570581-5A437D00-0AF1-4B44-BF59-7AE93509F603Q34644418-28D2F9F6-7D11-4C3A-9D84-DDFE2EF80854Q34987180-2D76066A-BF2B-4132-99B6-E85D2D421038Q35024682-A2707869-7901-4496-90B0-0C3ADE68BE83Q35104034-CD0E5C7A-AB99-4565-BAFA-FC3CDFBB258BQ35309119-1889922E-AAC7-4792-83A8-31B36D47B95CQ35634273-C0F0CE09-42CE-4F46-8DF1-7C9146D1269EQ35641886-921E2EFA-A642-4520-AC41-53BE45CEFA4BQ35835560-70ECA4FC-A341-43D7-AC67-D3BC92E7D32CQ36142761-4173D0E7-EFB6-4877-BEC8-C941F35142BDQ36492806-DC1D4952-A0E9-46DC-8BBC-5E89F85584B1Q37633550-7483724F-4CCA-4016-ADD1-6E40E3FDB215Q38087982-2D13D0A2-931B-4A4D-91BD-0FC9A31D02FCQ38825793-D0B830BC-814A-4EA1-8B3C-F9C863E9F935
P2860
Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Characterization of the microh ...... using SELDI-TOF-MS immunoassay
@ast
Characterization of the microh ...... using SELDI-TOF-MS immunoassay
@en
Characterization of the microh ...... using SELDI-TOF-MS immunoassay
@nl
type
label
Characterization of the microh ...... using SELDI-TOF-MS immunoassay
@ast
Characterization of the microh ...... using SELDI-TOF-MS immunoassay
@en
Characterization of the microh ...... using SELDI-TOF-MS immunoassay
@nl
prefLabel
Characterization of the microh ...... using SELDI-TOF-MS immunoassay
@ast
Characterization of the microh ...... using SELDI-TOF-MS immunoassay
@en
Characterization of the microh ...... using SELDI-TOF-MS immunoassay
@nl
P2860
P356
P1433
P1476
Characterization of the microh ...... using SELDI-TOF-MS immunoassay
@en
P2093
Jens Raila
Kerstin Wirth
P2860
P2888
P356
10.1186/1477-5956-2-5
P577
2004-09-01T00:00:00Z
P5875
P6179
1037963687